News
Phase 2a TREE study assesses safety and efficacy of leriglitazone Minoryx Therapeutics has dosed the first patient in its phase 2a TREE study, which evaluates the safety and efficacy of leriglitazone ...
Scientists have developed a new transgene control system that shows early promise for treating rare brain disorder Rett syndrome. Preclinical studies have demonstrated that the microRNA system - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results